Nexalin Technology Announces Initiation of Patient Recruitment for UCSD's TBI & PTSD Clinical Study Following IRB Approval
Portfolio Pulse from
Nexalin Technology has begun patient recruitment for a clinical study at UCSD focused on TBI and PTSD, following IRB approval. The study will use HALO™ Clarity Devices, which have been successfully shipped for the first phase of trials.
February 28, 2025 | 1:45 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Nexalin Technology has initiated patient recruitment for a clinical study on TBI and PTSD at UCSD, using their HALO™ Clarity Devices. This follows IRB approval and successful shipment of devices for the trial's first phase.
The initiation of patient recruitment and the successful shipment of HALO™ Clarity Devices for a clinical study at UCSD is a positive development for Nexalin Technology. It indicates progress in their clinical trials, which could lead to future product validation and potential market opportunities.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100